Our data thus support a future modulation of NKCC1, indirectly[75, 78] or directly,[33, 71] as a mode of pharmacological modulation of the ventriculomegaly often observed in patients following a hemorrhagic event. This evidence concerns the gene SLC12A2 and Ventriculomegaly.